secwatch.observer — SEC 8-K summary
======================================

Issuer:     OS Therapies Inc (OSTX)
CIK:        0001795091
Form:       8-K
Filed at:   2025-04-09T23:59:59+00:00
Accession:  0001213900-25-030375
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve issuance of shares exceeding 20% of outstanding common stock
--------------------------------------------------------------------------------

- Special meeting held April 9, 2025; proposal passed with 11,587,018 votes in favor (99.3% of votes cast).
- Approval covers conversion of 1,775,750 Series A Preferred shares and exercise of warrants from private placement.
- Issuance without regard to conversion/exercise limits can dilute existing holders by at least 20%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1795091/000121390025030375/0001213900-25-030375-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1795091/000121390025030375/ea0237768-8k_ostherapies.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-030375

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer